Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206379
Max Phase: Preclinical
Molecular Formula: C34H51N2O10P
Molecular Weight: 678.76
Associated Items:
ID: ALA5206379
Max Phase: Preclinical
Molecular Formula: C34H51N2O10P
Molecular Weight: 678.76
Associated Items:
Canonical SMILES: CCCCCCCCCCCOc1cccc(CCC(=O)NC[C@@H](O)COP(=O)(O)OC[C@H](NC(=O)c2ccc(C)cc2)C(=O)O)c1
Standard InChI: InChI=1S/C34H51N2O10P/c1-3-4-5-6-7-8-9-10-11-21-44-30-14-12-13-27(22-30)17-20-32(38)35-23-29(37)24-45-47(42,43)46-25-31(34(40)41)36-33(39)28-18-15-26(2)16-19-28/h12-16,18-19,22,29,31,37H,3-11,17,20-21,23-25H2,1-2H3,(H,35,38)(H,36,39)(H,40,41)(H,42,43)/t29-,31+/m1/s1
Standard InChI Key: KLIGFZBOUZXBPW-VEEOACQBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 678.76 | Molecular Weight (Monoisotopic): 678.3281 | AlogP: 5.33 | #Rotatable Bonds: 25 |
Polar Surface Area: 180.72 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.89 | CX Basic pKa: | CX LogP: 5.76 | CX LogD: 0.05 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.07 | Np Likeness Score: -0.21 |
1. Sayama M, Uwamizu A, Ikubo M, Chen L, Yan G, Otani Y, Inoue A, Aoki J, Ohwada T.. (2021) Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine., 64 (14.0): [PMID:34233115] [10.1021/acs.jmedchem.1c00347] |
Source(1):